Gender | |
 Female | 4 |
 Male | 6 |
Age | |
 Median (years) | 73 |
 Range (years) | 48–82 |
TNM-Stage classification, 8th edition | |
 IIb | 1 |
 IIIa | 5 |
 IIIb | 3 |
 IIIC | 1 |
Primary tumor site | |
 Upper lobe | 4 |
 Central | 2 |
 Lower lobe | 4 |
Performance status | |
 ECOG 0 | 1 |
 ECOG 1 | 8 |
 ECOG 2 | 1 |
COPD | |
 Grade 0–1 | 6 |
 Grade 2 | 4 |
Response to induction treatment | |
 CR | 1 |
 PR | 6 |
 NC | 2 |
 PD | 1 |
CTV volume (ccm) | |
 Median | 324.4 |
 Range | 98.3–653.9 |
IMRT/ VMAT | |
 9-Field | 3 |
 12-Field | 6 |
 VMAT | 1 |
Time from CBCT2 to end of treatment (min) | |
 Median | 7.7 |
 Range | 5.9–10.2 |